AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 7 added, 0 cutMore adding
Key stats
Fundamentals Oct 1- Open
- $66.32
- 52-wk high
- $89.64
- High
- $66.76
- 52-wk low
- $58.72
- Low
- $65.61
- Prev close
- $66.78
- Mkt cap
- $30.02B
- P/E
- 15.3x
- Volume
- 3.30M
- Fwd P/E
- 12.1x
- Beta
- 0.82
- Div yield
- 0.21%
- P/S
- 1.4x
- P/B
- 2.7x
- Profit margin
- +9.3%
- Op margin
- +15.0%
- ROE
- +19.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about GEHC filings
Are insiders buying or selling GE HealthCare Technologies Inc. (GEHC) stock?
Neither. GE HealthCare Technologies Inc. (GEHC) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded GEHC recently?
None. No member of Congress disclosed a GEHC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this GEHC smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (3)
- P7
Point72
$65.7M
added
- CI
Citadel
$59.5M
added
- AQ
AQR
$34.2M
added
What insiders are doing
Buys (3)
- LK
Lobo Kevin
$642K
bought
- HR
Hochman Rodney F
$100K
bought
- YW
Yang Watkin Phoebe L.
$63K
bought
What Congress is doing
Sells (2)
How top traders are positioned
No tracked top-trader positions in GEHC right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 1.9% above what analysts expected.
Earnings per share
$1.04 expected
Revenue
No comparable estimate
Reports Nov 4, 2026, in 34 days
Estimates as of Sep 30, 2026
EPS expected
$1.18 to $1.25
Revenue expected
17 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.14B | $4.67B | $5.13B | $5.29B |
| Cost of what it sold | $3.15B | $2.13B | $3.15B | $3.12B |
| Gross profit | $1.99B | $2.54B | $1.98B | $2.18B |
| What it spent | ||||
| Research and development | $292.0M | $362.0M | $345.0M | $323.0M |
| Sales and admin | $1.04B | $1.11B | $1.12B | $1.12B |
| Other operating costs | — | $403.0M | — | — |
| Total operating expenses | $1.34B | $1.88B | $1.46B | $1.44B |
| What was left | ||||
| Operating profit | $653.0M | $664.0M | $515.0M | $739.0M |
| Interest on debt | $123.0M | $103.0M | $96.0M | $114.0M |
| Profit before tax | $643.0M | $202.0M | $505.0M | $693.0M |
| Tax | $179.0M | $54.0M | $94.0M | $119.0M |
| Net profit | $446.0M | $184.0M | $389.0M | $573.0M |
| EBITDA | $902.0M | $865.0M | $755.0M | $953.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Licensable picture: GE Healthcare brand logo
NeutralSep 30GE HealthCare stock pre-market at EUR 58.59: minus 0.02 percent
NeutralSep 30Can ResMed (ASX:RMD) Hit Its Outlook After Retiring the Astral Ventilator?
NeutralSep 30Licensable picture: GE Healthcare brand logo
NeutralSep 29Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
BullishSep 29GE HealthCare Technologies Inc. (GEHC) Latest Stock News & Headlines
NeutralSep 29Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
BullishSep 28Nurses dissatisfied with AI implementation, feel 'watched' by AI
Leans bearishSep 28